Bioventus (BVS) traded down -0.53 % during a 24 hours period ending at 03:33 AM Central Europe on Tuesday 27th. One Bioventus stock can currently be bought for about USD 14.72 on popular exchanges. Current supply of Bioventus stocks is 84.2 mn. Bioventus has a current market capitalization of USD 1.3 bn and approximately USD 5.8 mn worth of Bioventus was traded on exchanges in the last 24 hours. Since last month end, Bioventus has traded 10.65 % up. Simple moving average of last 200 days is at USD 10.74. The highest price of past 52 weeks was recorded at USD 15.89 on 08/05/2026. 52 weeks low was at USD 6.47 on 11/21/2025.
Here is how related stocks have performed in the past 24 hours:
Dorchester Minerals (DMLP) traded up 2.2 % and now trades at USD 30.58. Dorchester Minerals has a market capitalisation of USD 1.5 bn. Current price/earnings ratio for Dorchester Minerals is 17.48.
Agilon Health (AGL) traded down -0.64 % and now trades at USD 90.34. Current market capitalisation for Agilon Health is USD 1.5 bn.
Ataibeckley (ATAI) traded down -5.38 % and now trades at USD 3.87. Current market capitalisation for Ataibeckley is USD 1.5 bn.
Structure Therapeutics (GPCR) traded down -3.37 % and now trades at USD 21.1. Structure Therapeutics has a market capitalisation of USD 1.5 bn.
Innoviva (INVA) traded down -1.9 % and now trades at USD 21.05. Innoviva has a market capitalisation of USD 1.5 bn. Current price/earnings ratio for Innoviva is 4.78.
About Bioventus
Bioventus Inc. is a medical device company operating in the Health Care sector with its base in Durham, United States. The company offers a range of products including ultrasound bone healing devices, musculoskeletal ultrasound devices, osteoarthritis pain treatments, bone fracture healing systems, and portable diagnostic systems. Bioventus serves global customers. You can find more information about the company and its products on their website at www.bioventus.com . The company’s stock is traded on the Nasdaq.